Form 8-K - Current report:
SEC Accession No. 0001299933-10-001600
Filing Date
2010-04-23
Accepted
2010-04-23 15:04:19
Documents
3
Period of Report
2010-04-20
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 LIVE FILING htm_37253.htm 8-K 11666
2 EX-99.1 exhibit1.htm EX-99.1 5404
3 GRAPHIC e29814-10111153949103c96e_1.jpg GRAPHIC 25067
  Complete submission text file 0001299933-10-001600.txt   53272
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 10767095
SIC: 2834 Pharmaceutical Preparations